期刊文献+

大肠杆菌表达人新型肿瘤坏死因子的纯化 被引量:10

Purification of the new type human tumor necrosis factor expressed in E. coli
下载PDF
导出
摘要 目的:制备符合临床要求的高纯度新型人肿瘤坏死因子(nhTNF),建立简单、高效的纯化途径.方法:用本室构建的nhTNF基因工程菌,经发酵、收菌、裂菌、硫酸铵盐析,Q-Sepharose及S-Sepharose层析,得到高活性、高纯度的nhTNF单一色谱峰,比活性达1×109U/mg蛋白.结果:nhTNF纯度达98%以上,活性回收率为79%.结论:纯化方法简单,且达到较好效果,为nhTNF的大规模制备和临床应用打下基础. Objective: To prepare the high purified recombinant new type human tumor necrosis factor (nhTNF) with effective method. Methods: nhTNF expressed in E. coli was collected, disrupted and partially purified through ammonium sulfate preipitation. Then the crude sample was further purified by Q Sepharose, S Sepharose ion exchange chromatography sequentially. In SDS polyacrylamine gel electrophoresis the homogeneity of purified TNF was observed. Its specific activity reached 1.1×10 9 U/mg protein. Result: The purity of nhTNF was more than 98%, and the recovery rate 79%. Conclusion: A simple and effective purification method for nhTNF is established. It is the basis for large scale preparation and clinical application of the nhTNF.
机构地区 第四军医大学
出处 《第四军医大学学报》 1997年第3期221-224,共4页 Journal of the Fourth Military Medical University
关键词 肿瘤坏死因子 表达产物 液相色谱 蛋白质 纯化 tumor necrosis factor chromatography protein purification
  • 相关文献

参考文献2

二级参考文献1

共引文献9

同被引文献49

  • 1何江,张杰.重组人TNF-α在大肠杆菌中的表达、纯化及生物学活性研究[J].中国优生与遗传杂志,2004,12(6):28-30. 被引量:3
  • 2刘丽,宋丽华,刘及.人TNFa基因克隆表达及表达产物的纯化和生物学活性分析[J].白求恩医科大学学报,1996,22(5):456-459. 被引量:2
  • 3王梁华,焦炳华.重组人肿瘤坏死因子α衍生物3a的制备及纯化[J].第二军医大学学报,1996,17(4):324-327. 被引量:6
  • 4鄂征.组织培养和分子细胞学技术[M].北京:北京出版社(第二版),1997.438-439.
  • 5J.萨姆布鲁克 E.F.弗里奇.分子克隆实验指南(第2版)[M].北京:科学出版社,1992.830-893.
  • 6Zhang Jie, Zheng Li, Zhao An, et al. Idetification of anti-TNF alpha peptides with consensus sequence [J]. Biochem Biophys Res Commun, 2003,310(4): 1181-1187.
  • 7Wang Q, Zeng M, Wang W, et al. The HMGB1 acidic tail regulates HMGB1 DNA binding specificity by a unique mechanism[J]. Biochem Biophys Res Commun, 2007,360:14-19.
  • 8Conti F, Ceccarelli F, Perricone C, et al. Rituximab infusion-related adverse event rates are lower in patients with systemic lupus erythematosus than in those with rheumatoid arthritis{J]. Rheumatology(Oxford), 2011,50(6):1148-52.
  • 9Bellizzi A, Barucca V, Fioriti D, et al. Early years of biological agents therapy in Crohn's disease and risk of the human polyomavirus JC reactivation [J]. J Cell Physiol, 2010,224(2): 316-326.
  • 10Zhou W, Hashimoto K, Goleniewska K, et al Prostaglandin 12 analogs inhibit proinflammatory cytokine production and T cell stimulatory function of dendritic cells[J]. J Immunol, 2007,178 (2):702-710.

引证文献10

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部